Delivery Order SPE2DB22D2005-SPE2DB23FJSW5
Award Date 8/10/23
Potential Completion Date 8/11/23
Potential Value $4.2K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a delivery order valued at $14,994.54 to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon (pancreatic enzyme replacement therapy) in 100-count packages. This firm fixed-price delivery order, awarded on July 14, 2025, with an ultimate completion date of July 15, 2025, represents a non-competitive award under an existing contract vehicle. The pharmaceutical will be supplied from the vendor's facility in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $14,406.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for 36,000 unit capsules of Creon (pancrelipase) in 100-count packages, with completion scheduled for September 10, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award is non-set-aside and was...
- The Defense Logistics Agency awarded a $195,270 delivery order to Amerisourcebergen Drug Corporation for 4561533512 CREON DR 36,000 unit capsules. The firm fixed price order is to supply 100 capsules and will be performed in Conshohocken, Pennsylvania from July 18-19, 2023. DLA procures pharmaceuticals and medical supplies to support all branches of the U.S. military through various prime vendor contracts. This delivery order was issued under an existing DLA prime vendor vehicle and will provide...
- The Defense Logistics Agency awarded a $16,574 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 36,000 unit capsules of Creon. As the prime contractor, Amerisourcebergen will deliver the pancreatic enzyme replacement therapy medication to a facility in Conshohocken, Pennsylvania under a one-day period of performance starting on July 11, 2023. The order was placed against an existing DLA contract vehicle in support of the Agency's medical supply procurement programs. No...
- The Defense Logistics Agency awarded a $3,717.57 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 36,000 units of Creon DR 100s capsules. The award, issued on July 25, 2025, with an ultimate completion date of July 28, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its Corporate Office location. This delivery order is issued under the company's existing Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,406.80 to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon DR 100s, with performance at the contractor's facility in Conshohocken, Pennsylvania. This is a firm fixed-price delivery order with an ultimate completion date of July 31, 2025, and represents a non-set-aside competitive award. The contract was issued on July 30, 2025, under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) vehicle...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of 36,000 unit capsules of Creon DR 100s with a ceiling value of $58,274.04. This firm fixed-price delivery order is scheduled for completion by September 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was competitively procured with no set-aside designation and represents a continuation of the...
- The Defense Logistics Agency awarded a delivery order valued at $4,587.60 to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon (pancreatic enzyme replacement therapy) in 100-count bottles. The award, issued on September 12, 2025, with an ultimate completion date of September 15, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...
- The Defense Logistics Agency awarded a $5,909.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of 36,000 unit capsules of Creon (pancrelipase) in 100-unit packages. The delivery order will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania, with completion scheduled for November 5, 2025. This award represents a non-set-aside, competitively awarded delivery order issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $8,474.88 to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon DR 100s, a pancreatic enzyme replacement medication. This firm fixed price delivery order, awarded on August 12, 2025, with completion scheduled for August 13, 2025, carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a routine pharmaceutical procurement...